Health Technology News

MALVERN, Pa.--(BUSINESS WIRE)--LifeScan (the "Company"), a world leader in blood glucose monitoring, today announced the appointment of Jonathan Salkin as Chief Executive Officer, effective immediately. Salkin will succeed Michael Hooks and James Rushing who have been serving as Co-Interim CEOs since January 2026. Hooks will continue to serve as Chairman of the Board and Rushing will continue in his roles as Executive Vice President and Chief Financial Officer. Salkin joins LifeScan with more t...

MINNEAPOLIS--(BUSINESS WIRE)--Provation, a leading provider of clinical productivity software, today announced the expansion of its cloud-based documentation platform, Provation® Apex, into orthopedic surgery. The new orthopedics module delivers voice-driven, billing-ready operative notes with immediate signoff – eliminating transcription delays, reducing documentation burden, and accelerating the orthopedic revenue cycle for ambulatory surgery centers. The expansion marks a significant milesto...

DALLAS--(BUSINESS WIRE)--SpinSci Technologies today announced a partnership with Primary Care Clinic of Texas, supporting the clinic's mission to deliver quality, affordable healthcare to uninsured and underinsured adults across North Texas. Founded in 2003, Primary Care Clinic of Texas is a nonprofit serving the Dallas-Fort Worth metroplex, with locations in Dallas, Lewisville, Plano, and Arlington. In more than two decades of operation, the clinic has delivered over 200,000 patient visits, co...

MADISON, Wis.--(BUSINESS WIRE)--Venture Investors Health Fund, one of the Midwest’s longest-standing healthcare-focused venture firms, today announced its rebrand to Clarevia Ventures, a new name that reflects the firm’s sharpened focus on helping early-stage medtech and life sciences companies navigate the path from breakthrough science to patient impact. The rebrand comes after years of evolution within the firm. While Clarevia has invested exclusively in healthcare since 2018, the new identi...

SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced U.S. Food and Drug Administration (FDA) clearance of ArteraAI Breast for use in patients with early-stage, hormone receptor-positive (HR+), HER2-negative invasive breast cancer. ArteraAI Breast is the first and only FDA-cleared digital pathology-based risk stratification tool for breast cancer. With clearances in both prostate and breas...

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the three months ended March 31, 2026 after market close on Wednesday, May 13, 2026 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time:   Wednesd...

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today released findings from a nationally distributed survey of 360 independent practice leaders, conducted in March 2026. The survey respondents resolved to remain independent and are counting on technology as a critical lever to drive practice performance. Technology Is Critical to Support Independent Practice Growth The survey found that despite real and...

ROCHESTER, N.Y.--(BUSINESS WIRE)--Turbett Surgical is proud to announce the appointment of Kevin Danahy as President and Chief Executive Officer. A visionary leader known for his "founder-mentality," Danahy joins the company with a mandate to instill a high-performance culture and lead the organization through its next era of clinical expansion and commercial excellence. Danahy most recently served at Pulse Biosciences in key executive roles, including President and CEO, during the company's cr...

PARIS--(BUSINESS WIRE)--Waiv, formerly Owkin Dx, a Paris-based company catalyzing AI precision testing, today announced it has entered a collaboration with Daiichi Sankyo (TSE: 4568) to lead digital pathology biomarker discovery for an antibody-drug conjugate (ADC) program. With deep expertise across diverse pathology and multimodal data, and a global data network spanning academic institutions, hospitals, and laboratories, Waiv has a proven track record delivering AI-powered biomarker solution...

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will deliver a company presentation at the 21st Annual Needham Technology, Media, & Consumer Conference on Thursday, May 14, at 11:45 – 12:25 PM Eastern Time, and will be participating in 1x1 meetings at this event. A webcast of the presentation will be available on the investo...